Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

被引：145
|
作者：
Brownlee, Wallace [1 ]
Bourdette, Dennis [2 ]
Broadley, Simon [3 ]
Killestein, Joep [4 ]
Ciccarelli, Olga [1 ,5 ]
机构：
[1] UCL Queen Sq Inst Neurol, Dept Neuroinflammat, Queen Sq MS Ctr, London, England
[2] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
[3] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast Campus, Nathan, Qld, Australia
[4] Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands
[5] Univ Coll London Hosp NIHR Biomed Res Ctr, London, England
来源：
NEUROLOGY | 2020年 / 94卷 / 22期
关键词：
D O I：
10.1212/WNL.0000000000009507
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The emergence of novel coronavirus 2019 (COVID-19)(1)and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).
引用
收藏
页码：949 / 952
页数：4
相关论文
共 50 条
  • [41] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    Siritho, Sasitorn
    Rattanathamsakul, Natthapon
    Detweeratham, Thammachet
    Prayoonwiwat, Naraporn
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [42] Diagnostic Challenges in Pediatric Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Yeshokumar, Anusha K.
    Banwell, Brenda L.
    JOURNAL OF PEDIATRIC NEUROLOGY, 2018, 16 (03) : 185 - 191
  • [43] Epidemiology of multiple sclerosis and neuromyelitis optica spectrum disorder in South Korea
    Kim, J.
    Seok, J. M.
    Lee, H. J.
    Kim, B. J.
    Min, J. -H.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 610 - 610
  • [44] Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea
    Kim, Jee-Eun
    Park, Sang-Hyun
    Han, Kyungdo
    Kim, Ho-Jin
    Shin, Dong-Wook
    Kim, Sung-Min
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (14) : 1837 - 1844
  • [45] The Impact of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorder Beyond Infection Risk
    Yin, Hexiang
    Zhang, Yao
    Xu, Yan
    Peng, Bin
    Cui, Liying
    Zhang, Shuyang
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [46] Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report
    Lisa Lohmann
    Felix Glaser
    Gabriel Möddel
    Jan D. Lünemann
    Heinz Wiendl
    Luisa Klotz
    BMC Neurology, 22
  • [47] Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report
    Lohmann, Lisa
    Glaser, Felix
    Moeddel, Gabriel
    Luenemann, Jan D.
    Wiendl, Heinz
    Klotz, Luisa
    BMC NEUROLOGY, 2022, 22 (01)
  • [48] The psychological effect of Covid19 pandemic on neuromyelitis optica spectrum disorder patients and their attitude change during the pandemic, after a year
    Mehdipour, Roshanak
    Ashtari, Fereshteh
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [49] Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations
    Guevara, Carlos
    Villa, Eduardo
    Silva Rosas, Carlos
    Diaz, Violeta
    Naves, Rodrigo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
  • [50] χ-Separation Imaging for Diagnosis of Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder
    Kim, Woojun
    Shin, Hyeong-Geol
    Lee, Hyebin
    Park, Dohoon
    Kang, Junghwa
    Nam, Yoonho
    Lee, Jongho
    Jang, Jinhee
    RADIOLOGY, 2023, 307 (01)
12345